Kids’ mental health app sees spike in users in COVID-19 crisisA mental health app for young people has seen a spike of 168% during the COVID-19 coronavirus outbreak Share XKids’ mental health app sees spike in users in COVID-19 crisishttps://pharmaphorum.com/news/kids-mental-health-app-sees-spike-in-users-in-covid-19-crisis/
Personalising digital mental health treatmentIn the age of smartphones and virtual reality, NHS trusts must evolve their approach to reach patients, and Share XPersonalising digital mental health treatmenthttps://pharmaphorum.com/views-analysis-digital/personalising-digital-mental-health-treatment/
NHS hospital trials algorithm to predict mental health crisesAn algorithm could be used by an NHS hospital in England to predict which people may experience a Share XNHS hospital trials algorithm to predict mental health criseshttps://pharmaphorum.com/news/nhs-hospital-trials-algorithm-to-predict-mental-health-crises/
Football-themed film launched for World Mental Health dayA new film that tackles mental health and social media from the perspective of football influencers has been Share XFootball-themed film launched for World Mental Health dayhttps://pharmaphorum.com/news/streaming-well-healthware-football-mental-health-film/
Deep learning could keep CBT therapists on track, says studyA study has shown that deep learning could be used to monitor therapists’ effectiveness at conducting cognitive behavioural Share XDeep learning could keep CBT therapists on track, says studyhttps://pharmaphorum.com/news/deep-learning-could-keep-cbt-therapists-on-track-says-study/
Researchers use AI to analyse voices and diagnose PTSDArtificial intelligence could be used to diagnose post-traumatic stress disorder (PTSD), according to preliminary study findings. Assessment of Share XResearchers use AI to analyse voices and diagnose PTSDhttps://pharmaphorum.com/news/researchers-use-ai-to-analyse-voices-and-diagnose-ptsd/
Karuna raises $68m to develop neurology drug KarXTKaruna Therapeutics has raised $68 million to further develop its neurology drug KarXT, which is in phase 2 Share XKaruna raises $68m to develop neurology drug KarXThttps://pharmaphorum.com/news/karuna-raises-68m-to-develop-neurology-drug-karxt/
FDA panel backs J&J’s potential depression blockbusterA panel of advisers to the FDA has voted in favour of approving Johnson & Johnson’s experimental nasal Share XFDA panel backs J&J’s potential depression blockbusterhttps://pharmaphorum.com/news/fda-panel-backs-jjs-potential-depression-blockbuster/
NICE backs digital CBT for youngsters with depressionNICE has recommended digital cognitive behavioural therapy (CBT) should be used as a first-line treatment for children and Share XNICE backs digital CBT for youngsters with depressionhttps://pharmaphorum.com/news/nice-backs-digital-cbt-for-youngsters-with-depression/
